Clene Inc. Warrant (CLNNW)

• Market cap: $6.91K
• 1 day: 5.19%
• 5 days: 13.15%
• 1 month: -18.86%
• 3 months: -20.00%
• 6 months: -43.20%
• Year to date: -39.06%
• 1 year: -17.68%
• 5 years: -97.16%
• 10 years: -97.16%
• Sector: Consumer Staples
• Industry: Packaged Foods

About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Employees: 76

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

33% more funds holding

Funds holding: 3 [Q4 2024] → 4 (+1) [Q1 2025]

0% more ownership

Funds ownership: 13.03% [Q4 2024] → 13.03% (+0%) [Q1 2025]

36% less capital invested

Capital invested by funds: $44.3K [Q4 2024] → $28.2K (-$16.1K) [Q1 2025]